|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
EBSCO_ocn946277671 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
160408s2016 nyu o 001 0 eng |
| 010 |
|
|
|a 2016017035
|
| 040 |
|
|
|a DLC
|b eng
|e rda
|e pn
|c DLC
|d OCLCF
|d N$T
|d EBLCP
|d SNK
|d DKU
|d AUW
|d MHW
|d BTN
|d IGB
|d D6H
|d VTS
|d AGLDB
|d AU@
|d G3B
|d S8J
|d S9I
|d STF
|d DLC
|d UKAHL
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCA
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 1100866446
|
| 020 |
|
|
|a 9781634849005
|q (ebook)
|
| 020 |
|
|
|a 1634849000
|
| 020 |
|
|
|z 9781634848756
|q (hardcover)
|
| 029 |
1 |
|
|a AU@
|b 000057274373
|
| 035 |
|
|
|a (OCoLC)946277671
|z (OCoLC)1100866446
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a QP552.A439
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
0 |
|a 616.99/40756
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Alpha-fetoprotein :
|b functions and clinical application /
|c editors, Nisha Lakhi and Michael Moretti (Department of Department of Obstetrics and Gynaecology, Richmond University Medical Centre, Staten Island, New York, USA).
|
| 264 |
|
1 |
|a Hauppauge, New York :
|b Nova Science Publisher's, Inc.,
|c [2016]
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a data file
|2 rda
|
| 490 |
0 |
|
|a Protein biochemistry, synthesis, structure and cellular functions.
|
| 500 |
|
|
|a Includes index.
|
| 588 |
0 |
|
|a Print version record and CIP data provided by publisher.
|
| 505 |
0 |
|
|a ALPHA-FETOPROTEIN FUNCTIONS AND CLINICAL APPLICATIONS; ALPHA-FETOPROTEIN FUNCTIONS AND CLINICAL APPLICATIONS; Library of Congress Cataloging-in-Publication Data; CONTENTS; FOREWORD AN OVERVIEW OF ALPHA-FETOPROTEIN RESEARCH THROUGHOUT THE DECADES; PREFACE; SECTION 1: ALPHA-FETOPROTEIN HISTORY AND NORMAL AND PATHOLOGICAL DEVELOPMENT; Chapter 1: THE HISTORY OF ALPHA-FETOPROTEIN DISCOVERY; ABSTRACT; INTRODUCTION; THE HISTORY OF ALPHA-FETOPROTEIN DISCOVERY; The First Ideas; THE MAIN SCIENTIFIC RESEARCHERS ENGAGED IN INVESTIGATION ON AFP FROM RUSSIA; INVESTIGATION ABOUT AFP IN THE WORLD
|
| 505 |
8 |
|
|a MOLECULAR ANALYSES OF AFP IN LAST PERIODCONCLUSION; ACKNOWLEDGMENTS; REFERENCES; Chapter 2: ALPHA-FETOPROTEIN IN DEVELOPMENT, AFTER LIVER INJURY, DURING CHEMICAL HEPATOCARCINOGENESIS AND IN LIVER CANCER: HOW THE STUDY OF ALPHA-FETOPROTEIN LED TO THE CONCEPT OF CANCER STEM CELLS; ABSTRACT; INTRODUCTION; Radioimmunoassay for AFP; AFP in Development; AFP IN RESTITUTIVE PROLIFERATION; Partial Hepatectomy (PH); Galactosamine; Allyl Alcohol (AA); Chemical Hepatocarcinogenesis; Diethylnitrosamine (DEN); Acetylaminofluorene-CCl4; Cyclic AAF; AFP Production by Hepatomas; Function of AFP; REFERENCES
|
| 505 |
8 |
|
|a Chapter 3: THE ROLE OF ALPHA-FETOPROTEIN IN HUMAN HEPATOCELLULAR CARCINOMAABSTRACT; INTRODUCTION; 1. BIOLOGICAL CHARACTERISTICS OF AFP; 1.1. Biological Functions of AFP; 2.1. AFP Is Involved in Multiple Signaling Transduction Pathways; 2. AFP IS INVOLVED IN IMMUNOSUPPRESSION PROCESS; 2.3. AFP Has Dual-Directional Regulation Effect in Cell ProliferationProcess; 3. CLINICAL USE OF AFP; REFERENCES; Chapter 4: USE OF ALPHA-FETOPROTEIN AND OTHER BIOMARKERS FOR ASSESSING HEPATOCELLULAR CARCINOMA RISK IN VIRAL HEPATITIS; ABSTRACT; INTRODUCTION
|
| 505 |
8 |
|
|a ROLE OF CURRENTLY AVAILABLE BIOMARKERS AND THEIR UTILIZATION IN HCC MANAGEMENTALPHA-FETOPROTEIN; AFP for Surveillance of CHB Patients; AFP for Surveillance of Patients with Chronic Hepatitis C; AFP as Prognostic Indicator for Outcomes after the Diagnosis of HCC; AFP for Allocation of Liver Organ for Liver Transplantation; AFP-L3%; DCP; OSTEOPONTIN; GLYPICAN; GOLGI PROTEIN 73; FIBROBLAST GROWTH FACTOR (FGF) AMPLIFICATION; CANAVANINOSUCCINATE; FIVE GENE SCORE; HIGH MET EXPRESSION; CONCLUSION; REFERENCES
|
| 505 |
8 |
|
|a Chapter 5: ALPHA-FETOPROTEIN IN A PROTEIN INTERACTION NETWORK: SYSTEMS BIOLOGY APPROACH IN DISCOVERY BIOMARKERS FOR HEPATOCELLULAR CARCINOMAABSTRACT; INTRODUCTION; BIOMARKER PROFILING TECHNOLOGIES; ALPHA-FETOPROTEIN IN COMBINED TESTING FOR HCC; KNOWN MOLECULAR FUNCTIONS OF HCC BIOMARKERS; EVALUABILITY OF NETWORK ANALYSIS IN HCC; CONCLUSION; REFERENCES; Chapter 6: ALPHA-FETOPROTEIN IN MALIGNANT PEDIATRIC TUMORS; ABSTRACT; INTRODUCTION; GERM CELL TUMORS; HEPATOBLASTOMA AND HEPATOCELLULAR CARCINOMA; AFP AND ASSOCIATED RARE PEDIATRIC SOLID CANCERS; CONCLUSION; REFERENCES
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Alpha fetoproteins.
|
| 650 |
|
2 |
|a alpha-Fetoproteins
|
| 650 |
|
6 |
|a Alpha-fœtoprotéines.
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Alpha fetoproteins
|2 fast
|
| 700 |
1 |
|
|a Lakhi, Nisha,
|e editor.
|
| 700 |
1 |
|
|a Moretti, Michael,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Alpha-fetoprotein.
|d Hauppauge, New York : Nova Science Publisher's, Inc., [2016]
|z 9781634848756
|w (DLC) 2016007435
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1286243
|z Texto completo
|
| 938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n AH30620782
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL4616099
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 1286243
|
| 994 |
|
|
|a 92
|b IZTAP
|
